Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Effectiveness of Adjunctive Gabapentin in Resistant Bipolar Disorder: Is It Due to Anxious-Alcohol Abuse Comorbidity?

Perugi, Giulio, Toni, Cristina, Frare, Franco, Ruffolo, Giuseppe, Moretti, Leonardo, Torti, Carlo, Akiskal, Hagop S. · 2002 · Journal of Clinical Psychopharmacology

Abstract

We evaluated effectiveness and predictors of response of gabapentin (GBP) as adjunctive treatment in a sample of 43 subjects with DSM-III-R bipolar disorder who were resistant to standard mood stabilizers. Diagnostic evaluation was performed by means of the Semistructured Interview for Mood Disorder. Clinical evaluation was performed at the beginning and end of the observation period by means of the Hamilton Rating Scale for Depression (HAM-D), the Young Mania Rating Scale, and the Clinical Global Impression Scale. GBP was administered as an adjunctive treatment for an 8-week period in combination with other mood stabilizers, benzodiazepines, antidepressants, and neuroleptics. Mean dosage +/- SD at week 8 was 1270 +/- 561.4 mg (range, 600-2400 mg). Adjunctive treatment with GBP was well tolerated by almost all the subjects; only three patients had to interrupt treatment before week 8, two because of inefficacy and one because of the appearance of side effects (ataxia and irritability); in other patients, the most frequent side effects were sedation, irritability, tremor, ataxia or motor instability, and nausea. Eighteen (41.9%) of 43 patients who began treatment were considered responders. Mean total HAM-D score showed a significant reduction during the 8 weeks of treatment. Analysis of the various HAM-D dimensions showed that the anxiety-somatization factor was the one with the greatest change. Seventeen of the 18 responder patients remained in remission for a period ranging from 4 to 12 months without clinically significant side effects or adverse events. One patient had to interrupt GBP treatment and be administered neuroleptics because of the reappearance of manic symptoms. Regarding response predictors, logistical regression analysis showed that the presence of panic disorder and alcohol abuse was associated with positive response. The results of the present study replicate prior studies indicating that GBP is an effective and well tolerated treatment in a large proportion of bipolar patients who are resistant to traditional mood stabilizers. More specifically, this drug appears to have antidepressant and anxiolytic properties. What is new in the present report is the suggestion that the utility of GBP in resistant bipolar disorder resides in its effectiveness against comorbid panic disorder and alcohol abuse.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004714-200212000-00008

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Research works printed but not linked: 8

  1. Wehr, 1987, Psychopharmacol Bull, 23, 61
  2. Sernyak, 1993, Psychopharmacol Bull, 29, 375
  3. Abou-Khalil, 1990, Epilepsia, 31, 644
  4. Stanton, 1997, Am J Psychiatry, 154, 287
  5. Garonna, 1998, Giorn Ital Psicopat, 2, 269
  6. Sokolski, 1999, Ann Clin Psychiatry, 11, 217, 10.3109/10401239909147073 · doi:10.3109/10401239909147073
  7. Carta, 1998b, Psychiatr Networks, 1–2, 7
  8. Hardoy, 1998, Psychiatr Networks, 1–2, 60

Cited by

See all 61

Metadata

Authors
Perugi, G., Toni, C., Frare, F., Ruffolo, G., Moretti, L., Torti, C., & Akiskal, H. S.
Affiliations
  • University of Pisa (IT)
  • University of California San Diego (US)
Corresponding author
  • Perugi, Giulio
  • Ruffolo, Giuseppe
  • Torti, Carlo
Venue
Journal of Clinical Psychopharmacology
Published
2002-12
Volume
22
Issue
6
Pages
584-591
ISSN
0271-0749 (ISSN-L)
OpenAlex
W1963927235
Cited by
61
References
47
Citations by year
2023: 1 · 2021: 5 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 2 · 2012: 4
FWCI
3.20
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
gabapentin, bipolar disorder, treatment-resistant bipolar disorder, adjunctive therapy, mood stabilizers, panic disorder, alcohol abuse, comorbidities, antidepressant effects, anxiolytic effects, predictors of treatment response, remission, adverse effects
MeSH terms
Gabapentin, Acetates, Adult, Aged, Alcoholism, Amines, Anticonvulsants, Anxiety Disorders, Bipolar Disorder, Cyclohexanecarboxylic Acids, Drug Resistance, Drug Therapy, Combination, Female, gamma-Aminobutyric Acid, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Sampling Studies, Comorbidity, Treatment Outcome, Antimanic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of Adjunctive Gabapentin in Resistant Bipolar Disorder: Is It Due to Anxious-Alcohol Abuse Comorbidity? https://app.cochat.ai/papers/10.1097/00004714-200212000-00008
The paper
Perugi, G., Toni, C., Frare, F., Ruffolo, G., Moretti, L., Torti, C., & Akiskal, H. S. (2002). Effectiveness of Adjunctive Gabapentin in Resistant Bipolar Disorder: Is It Due to Anxious-Alcohol Abuse Comorbidity? Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-200212000-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.